The response time was less than 30 s and a good reproducibility over a period of 3 months was observed.
A concomitant reduction of non-transferrin-bound iron (NTBI) at six months was observed (2.1 ± 1.0 vs 1.7 ± 1.2 μM).
Extreme N-leaching due to percolated snowmelt in early spring (a 35-cm movement within 0.5 months) was observed in the apple orchard planted on Andosol soil.
After intraportal delivery of this vector, high-level, stable transgene expression of angiostatin lasting for at least 6 months was observed locally in hepatocytes.
Effective treatment at 3 months was observed in only 76 cases.
In this subgroup of women in our study, a clinically relevant reduction of migraine attacks after 6 months was observed.
A sustained complete response (107+ months) was observed in one patient; one partial response and one mixed response each also were observed.
By monitoring daily changes in noise ACF, a systematic phase delay lasting about 4 months was observed for two major periods of earthquake activities.
Minor responses were observed in two patients: stable disease > or = 6 months was observed in two out of twenty-one evaluable patients.Full doses of capecitabine and imatinib mesylate were not tolerable.
However, a relatively shorter duration of response (range 5 13 months) was observed in all four patients who attained PR, which was correlated with the in vivo expansion and persistence of the CAR-T cells.
Interestingly, the difference between groups in muscular strength, after 3 months, was observed only in the flexor muscles, also evidenced by peak torque to body weight ratio (SG = 89.5 ± 19.1 % vs. CART-G = 116 ± 30.1 %).
